Kenji Ishitsuka

18PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyPsychology of ageingHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 15, 2025
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.

Makoto Yoshimitsu, Ilseung Choi, Shigeru Kusumoto

|Feb 03, 2025
Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation.

Shigeo Fuji, Masahito Tokunaga, Koji Kato

|Jun 07, 2024
Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan.

Kenji Ishitsuka, Tomoharu Yasukawa, Yukie Tsuji

|Nov 03, 2023
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.

Koji Izutsu, Takahiro Kumode, Junichiro Yuda

|Mar 25, 2023
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy.

Shigeo Fuji, Yoshitaka Inoue, Junya Makiyama

|Mar 15, 2023
T cell lymphoma: time to make discoveries and advance treatment.

Kenji Ishitsuka

Pageof 3

Frequent Collaborators

10 joint publications

Makoto Yoshimitsu

5 joint publications

Masahito Tokunaga

5 joint publications

Atae Utsunomiya

5 joint publications

Kisato Nosaka